Your browser doesn't support javascript.
loading
Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic.
Gkalpakiotis, Spyridon; Cetkovska, Petra; Arenberger, Petr; Dolezal, Tomas; Arenbergerova, Monika; Velackova, Barbora; Fialova, Jorga; Kojanova, Martina.
Afiliação
  • Gkalpakiotis S; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Charles University, Prague, Czech Republic. spyros@centrum.cz.
  • Cetkovska P; Department of Dermatovenereology, Faculty of Medicine and University Hospital, Charles University, Pilsen, Czech Republic.
  • Arenberger P; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Charles University, Prague, Czech Republic.
  • Dolezal T; Value Outcomes, Prague, Czech Republic.
  • Arenbergerova M; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Charles University, Prague, Czech Republic.
  • Velackova B; Value Outcomes, Prague, Czech Republic.
  • Fialova J; Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
  • Kojanova M; Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
Dermatol Ther (Heidelb) ; 11(4): 1345-1355, 2021 Aug.
Article em En | MEDLINE | ID: mdl-34089479
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article